BioCentury
ARTICLE | Company News

BioBlocks, Visionary Pharmaceuticals deal

January 20, 2014 8:00 AM UTC

The companies partnered to discover and develop small molecule inhibitors of serum/glucocorticoid regulated kinase 1 (SGK1) to treat cancer. The partners said the kinase has been implicated in breast...